Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
EDAP TMS
EDAP
EDAP TMS
Tariffs And Delays Will Hinder Progress Though Trials Offer Hope
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
15 Aug 25
Updated
15 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$1.50
10.0% undervalued
intrinsic discount
15 Aug
US$1.35
Loading
1Y
-66.7%
7D
-0.7%
Author's Valuation
US$1.5
10.0% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$1.5
10.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-22m
63m
2014
2017
2020
2023
2025
2026
2028
Revenue €55.4m
Earnings €6.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
15.20%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.61%
Calculation
€6.92m
Earnings '28
x
8.83x
PE Ratio '28
=
€61.08m
Market Cap '28
€61.08m
Market Cap '28
/
37.96m
No. shares '28
=
€1.61
Share Price '28
€1.61
Share Price '28
Discounted to 2025 @ 8.63% p.a.
=
€1.26
Fair Value '25
€1.26
Fair Value '25
Converted to USD @ 1.1647 EUR/USD Exchange Rate
=
US$1.47
Fair Value '25
